| 25 Aug, 07:28 pm | — | … | In terms of provisions of Regulation 30 (read with Part A of Schedule III) and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ( Listing Regulations ), we wish to inform you that the Company is in receipt of an Adjudication Order passed by the Commissioner of Customs, Nhava Sheva-II, JNCH. | nse |
| 25 Aug, 06:50 pm | — | … | Wockhardt Ltd - 532300 - Disclosure under Regulation 30A of LODR | bse |
| 10 Aug, 06:38 pm | — | … | Pursuant to Regulation 32(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Regulation 173A of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, please find enclosed Monitoring Agency Report towards utilization of proceeds of Qualified Institutions Placement ( QIP ) for the quarter ended June 30, 2026, issued by CRISIL Ratings Limited, duly reviewed and taken on record by the Board of Directors & Audit Committee of the Company. | nse |
| 10 Aug, 06:38 pm | — | … | Wockhardt Ltd - 532300 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report | bse |
| 10 Aug, 06:11 pm | — | … | Wockhardt Limited has informed the Exchange regarding a press release dated August 10, 2026, titled Wockhardt Antibiotic Academy, an initiative for Patient-Centric Scientific Dialogue to Tackle Multidrug Resistance . | nse |
| 10 Aug, 06:05 pm | — | … | Wockhardt Ltd - 532300 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 10 Aug, 04:48 pm | — | … | Pursuant to Regulation 30 of the Listing Regulations, please find enclosed Press Release on theUnaudited Financial Results (Standalone and Consolidated) for the quarter ended 30th June, 2026. | nse |
| 10 Aug, 04:48 pm | — | … | Wockhardt Ltd - 532300 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 10 Aug, 03:30 pm | — | … | Wockhardt Ltd - 532300 - Financial Results For The Quarter Ended 30Th June, 2026 | bse |
| 10 Aug, 03:24 pm | — | … | Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations ); and in continuation to our letter bearing reference no: WOCK/SEC/SE/2026-27/027 dated 4th August, 2026, we wish to inform you that the Board of Directors of the Company, at its meeting held today i.e. 10th August, 2026, inter-alia, has approved the Un-Audited Financial Results (Standalone & Consolidated) for the quarter ended 30th June, | nse |
| 04 Aug, 05:54 pm | — | … | Wockhardt Ltd - 532300 - Board Meeting Intimation for Approval Of The Un-Audited Financial Results (Standalone & Consolidated) Of The Company For The Quarter Ended 30Th June, 2026. | bse |
| 17 Jul, 08:33 pm | — | … | Wockhardt Ltd - 532300 - Reg. 34 (1) Annual Report. | bse |
| 17 Jul, 08:24 pm | — | … | The 27th Annual General Meeting ( 27th AGM ) of the Members of Wockhardt Limited will be held on Monday, 10th August, 2026 at 3:30 p.m. (IST), through Video Conferencing ( VC )/ Other Audio Visual Means ( OAVM ). Pursuant to Regulations 29, 30 and 34(1) of the SEBI Listing Regulations, we submit herewith the Notice convening the 27th AGM and the Annual Report for the Financial Year 2025-26, including the Business Responsibility and Sustainability Report of the Company for the period ( Annual Rep | nse |
| 30 Jun, 12:50 pm | — | … | Wockhardt Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. | nse |
| 11 Jun, 12:40 pm | investor_meet | 1 | Company submitted the transcript of the investor meeting/con-call held on 4 June 2026 under SEBI Reg 30 for records. | nse |
| 04 Jun, 04:24 pm | — | … | Wockhardt Ltd - 532300 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 04 Jun, 04:23 pm | — | … | Wockhardt Limited has informed the Exchange about Investor Presentation | nse |
| 01 Jun, 08:44 pm | — | … | Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Company will hold an Investor Meet on Thursday, 4th June, 2026 at 4:00 pm IST. | nse |
| 30 May, 06:21 pm | — | … | Wockhardt Ltd - 532300 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 30 May, 06:15 pm | — | … | Wockhardt Limited has informed the Exchange regarding a press release dated May 29, 2026, titled " Wockhardt Receives U.S. FDA Approval for ZAYNICH (cefepime and zidebactam), a Novel Intravenous Antibiotic for the Treatment of Adult Patients with Complicated Urinary Tract Infection Including Pyelonephritis. | nse |
| 28 May, 04:41 pm | — | … | Wockhardt Ltd - 532300 - Compliances-Reg.24(A)-Annual Secretarial Compliance | bse |
| 28 May, 09:18 am | — | … | Pursuant to Regulation 30 of Listing Regulations, please find enclosed Press Release titled, Indian drug regulator grants marketing authorization to Wockhardt's breakthrough antibiotic, ZAYNICH® (Zidebactam/ Cefepime), for treatment of complicated urinary tract infections including pyelonephritis with concurrent Gram-negative bacteremia. | nse |
| 28 May, 09:16 am | — | … | Wockhardt Ltd - 532300 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 21 May, 02:39 pm | — | … | Wockhardt Ltd - 532300 - Announcement under Regulation 30 (LODR)-Credit Rating | bse |
| 21 May, 02:24 pm | — | … | Wockhardt Limited has informed the Exchange about Credit Rating | nse |
| 04 May, 06:44 pm | — | … | Wockhardt Ltd - 532300 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report | bse |
| 04 May, 06:34 pm | — | … | Pursuant to Regulation 32(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Regulation 173A of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, please find enclosed Monitoring Agency Report towards utilization of proceeds of Qualified Institutions Placement ( QIP ) for the quarter ended March 31, 2026, issued by CRISIL Ratings Limited, duly reviewed and taken on record by the Board of Directors & Audit Committee of the Company | nse |
| 04 May, 06:34 pm | — | … | Wockhardt Ltd - 532300 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 04 May, 06:24 pm | — | … | In terms of provisions of Regulation 30 (read with Part A of Schedule III) and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( Listing Regulations ), we wish to inform you that the Board of Directors of the Company, at its meeting held today i.e. 4th May, 2026, inter-alia, has identified and designated Ms. Annapurna Das, President (India Business & Emerging Markets (NCE)), Mr. Om Narayan, Senior Vice President (Biotech Research Centre | nse |
| 04 May, 03:52 pm | — | … | Wockhardt Ltd - 532300 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 04 May, 03:44 pm | — | … | Pursuant to Regulation 30 of the Listing Regulations, please find enclosed Press Release on theAudited Financial Results (Standalone and Consolidated) for the quarter and the financial yearended 31st March, 2026. | nse |
| 04 May, 03:32 pm | — | … | Pursuant to Regulation 30 and 33 of Listing Regulations read with Schedule III of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations ); and in continuation to our letter bearing reference no. Ref. No.: WOCK/SEC/SE/2026-27/006 dated 28th April, 2026, we wish to inform you that the Board of Directors of the Company, at its meeting held today i.e. 4th May, 2026, inter-alia, has approved:i. the Audited Financial Results an | nse |
| 04 May, 03:29 pm | — | … | Pursuant to Regulation 30 and 33 of Listing Regulations read with Schedule III of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations ); and in continuation to our letter bearing reference no. Ref. No.: WOCK/SEC/SE/2026-27/006 dated 28th April, 2026, we wish to inform you that the Board of Directors of the Company, at its meeting held today i.e. 4th May, 2026, inter-alia, has approved:i. the Audited Financial Results an | nse |
| 28 Apr, 03:49 pm | — | … | Wockhardt Ltd - 532300 - Board Meeting Intimation for Intimation Of The Meeting Of Board Of Directors Of Wockhardt Limited ('The Company') | bse |
| 30 Mar, 08:59 am | — | … | Wockhardt Ltd - 532300 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 30 Mar, 08:58 am | — | … | Pursuant to Regulation 30 of Listing Regulations, please find enclosed Press Release -"Wockhardt's Zaynich® (Zidebactam/Cefepime) Receives Favourable Recommendation from CDSCO's Subject Expert Committee for Treatment of Gram-Negative Infections". | nse |
| 19 Feb, 03:50 pm | — | … | Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular SEBI/HO/CFD/PoD2/CIR/P/0155 dated 11th November, 2024, we wish to inform you that NSE Sustainability Ratings and Analytics Limited, a SEBI-Registered ESG rating provider, has voluntarily assigned an ESG rating of 65 (Aspiring) for the year 2025 as part of its ESG assessment process.The rating comprises a score of 51 for Environmental, 70 for Social, and 74 for | nse |
| 10 Feb, 05:11 pm | — | … | Wockhardt Ltd - 532300 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report | bse |
| 10 Feb, 05:09 pm | — | … | Pursuant to Regulation 32(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Regulation 173A of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, please find enclosed Monitoring Agency Report towards utilization of proceeds of Qualified Institutions Placement ( QIP ) for the quarter ended December 31, 2025, issued by CRISIL Ratings Limited, duly reviewed and taken on record by the Board of Directors & Audit Committee of the Comp | nse |
| 10 Feb, 03:04 pm | — | … | Pursuant to Regulation 30 of the Listing Regulations, please find enclosed Press Release on the Un-audited Financial Results (Standalone and Consolidated) for the quarter and nine months ended 31st December, 2025. | nse |
| 10 Feb, 03:03 pm | — | … | Wockhardt Ltd - 532300 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 10 Feb, 02:44 pm | — | … | Wockhardt Ltd - 532300 - Outcome Of The Board Meeting | bse |
| 10 Feb, 02:32 pm | — | … | Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations ); and in continuation to our letter bearing reference no: WOCK/SEC/SE/2025-26/065 dated 4th February, 2026, we wish to inform you that the Board of Directors of the Company, at its meeting held today i.e.10th February, 2026, inter-alia, has approved the Un-Audited Financial Results (Standalone & Consolidated) for the quarter and nine month | nse |
| 04 Feb, 02:44 pm | — | … | Wockhardt Ltd - 532300 - Board Meeting Intimation for Intimation Of The Meeting Of Board Of Directors Of Wockhardt Limited ('The Company') | bse |
| 03 Feb, 04:25 pm | — | … | In terms of provisions of Regulation 30 (read with Part A of Schedule III) and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( Listing Regulations ), we wish to inform you that, Dr. Sanjeev Kumar Sharma, President - Manufacturing, Quality & R&D, designated as Senior Management Personnel (SMP) of the Company, has tendered his resignation from the services of the Company effective from close of business hours of 2nd February, 2026 due | nse |
| 03 Feb, 04:10 pm | — | … | Wockhardt Ltd - 532300 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 27 Jan, 09:05 am | — | … | Pursuant to Regulation 30 of Listing Regulations, please find enclosed Press Release Wockhardt s Fifth Novel Antibiotic, Foviscu® (WCK 4282), Matches Gold-Standard Meropenem in pivotal Phase 3 Trial as First-Line Therapies Fail Against Rising Resistance . | nse |
| 27 Jan, 09:00 am | — | … | Wockhardt Ltd - 532300 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 16 Jan, 04:37 pm | — | … | Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, we wish to inform you that CFC Finlease Private Limited, a SEBI-licensed ESG rating provider, has voluntarily assigned an ESG rating of 70 for the year 2025 as part of its ESG assessment process. | nse |
| 07 Jan, 09:06 am | — | … | Wockhardt Ltd - 532300 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |